Literature DB >> 16929481

Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation.

Martin Ahlemann1, Reinhard Zeidler, Stephan Lang, Brigitte Mack, Markus Münz, Olivier Gires.   

Abstract

Molecular processes controlling mRNA translation are complex, multilayered, and their deregulation can lead to cancer pathogenesis. Eukaryotic initiation factor 3 (eIF3) is involved in the initiation process of protein translation and overexpression of its subunit eukaryotic translation initiation factor i (eIF3i) has been observed in carcinomas. Nevertheless, the potential role of eIF3i in carcinogenesis is poorly understood. Here, we show that in vitro overexpression of human eIF3i resulted in cell size increase, proliferation enhancement, cell-cycle progression, and anchorage-independent growth. Without external stimuli, eIF3i overexpressing cells arrested in G1/G0 phase, demonstrating the requirement of additional growth signals. Inhibition of the kinase mTOR, a key player in the integration of nutrition and growth signals into protein synthesis, with rapamycin reduced serine phosphorylation of eIF3i and resulted in a loss of anchorage-independent growth. Thus, eIF3i overexpression fosters the integration of growth signals by mTOR into the mRNA translation process, promoting protein synthesis and tumor growth. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929481     DOI: 10.1002/mc.20269

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  15 in total

1.  Elucidation of changes in molecular signalling leading to increased cellular transformation in oncogenically progressed human bronchial epithelial cells exposed to radiations of increasing LET.

Authors:  Liang-Hao Ding; Seongmi Park; Yang Xie; Luc Girard; John D Minna; Michael D Story
Journal:  Mutagenesis       Date:  2015-05-22       Impact factor: 3.000

2.  The RNA recognition motif of eukaryotic translation initiation factor 3g (eIF3g) is required for resumption of scanning of posttermination ribosomes for reinitiation on GCN4 and together with eIF3i stimulates linear scanning.

Authors:  Lucie Cuchalová; Tomás Kouba; Anna Herrmannová; István Dányi; Wen-Ling Chiu; Leos Valásek
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

3.  Localization of transforming growth factor beta receptor II interacting protein-1 in bone and teeth: implications in matrix mineralization.

Authors:  Amsaveni Ramachandran; Sriram Ravindran; Anne George
Journal:  J Histochem Cytochem       Date:  2012-01-19       Impact factor: 2.479

4.  TRIP-1: a regulator of osteoblast function.

Authors:  Diana Metz-Estrella; Jennifer H Jonason; Tzong-Jen Sheu; Rachel M Mroczek-Johnston; J Edward Puzas
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

5.  eIF3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.

Authors:  Ji-Ye Yin; Zizheng Dong; Jian-Ting Zhang
Journal:  Methods Mol Biol       Date:  2017

Review 6.  Translational control in cancer etiology.

Authors:  Davide Ruggero
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

Review 7.  The cancerous translation apparatus.

Authors:  Craig R Stumpf; Davide Ruggero
Journal:  Curr Opin Genet Dev       Date:  2011-05-03       Impact factor: 5.578

8.  EIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and β-catenin activation.

Authors:  J Qi; Z Dong; J Liu; J-T Zhang
Journal:  Oncogene       Date:  2013-09-23       Impact factor: 9.867

Review 9.  Role of RONS and eIFs in Cancer Progression.

Authors:  Yasmeen Ahmed Salaheldin; Salma Sayed Mohamed Mahmoud; Ebenezeri Erasto Ngowi; Vivian Aku Gbordzor; Tao Li; Dong-Dong Wu; Xin-Ying Ji
Journal:  Oxid Med Cell Longev       Date:  2021-07-05       Impact factor: 6.543

10.  The Role of Translational Regulation in Survival after Radiation Damage; an Opportunity for Proteomics Analysis.

Authors:  Stefanie Stickel; Nathan Gomes; Tin Tin Su
Journal:  Proteomes       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.